Zobrazeno 1 - 10
of 165
pro vyhledávání: '"E Weidekamm"'
Autor:
I Meyer, B. Roos, J. Maares, J. Sauer, T. Brown, M. Schleimer, A. H. Schmitt-Hoffmann, E. Weidekamm
Publikováno v:
Clinical and Experimental Dermatology. 36:12-17
Summary Background. Alitretinoin, like all retinoids, is teratogenic, and can only be given to women of childbearing potential if pregnancy is excluded and a strict contraceptive programme is followed. Aim. This study was designed to determine whethe
Autor:
P. T. Leese, J. Sauer, M. Schleimer, J. Maares, E. Weidekamm, B. Roos, A. H. Schmitt-Hoffmann, A. Schoetzau
Publikováno v:
Clinical and Experimental Dermatology. 36:4-11
BACKGROUND: Alitretinoin (9-cis retinoic acid) is currently registered in many European countries and in Canada as the only licensed treatment for severe chronic hand eczema unresponsive to potent topical corticosteroids. Alitretinoin like all retino
Publikováno v:
European Journal of Clinical Pharmacology. 54:615-619
Objective: To assess the bioequivalence between a generic tablet of mefloquine (Mephaquin® = M1) with the reference tablet (Lariam® = M2) in healthy volunteers. Methods: This open label, randomized two-way cross-over study was performed in a single
Autor:
A. Högemann, J. F. W. Hoogkamer, C. H. Kleinbloesem, A. Nokhodian, M. J. A. Ouwerkerk, E. Weidekamm, Wilhelm Kirch
Publikováno v:
European Journal of Clinical Pharmacology. 54:341-345
Objective: The influence of liver disease on the pharmacokinetics of candesartan, a long-acting selective AT1 subtype angiotensin II receptor antagonist was studied. Methods: Twelve healthy subjects and 12 patients with mild to moderate liver impairm
Autor:
A H, Schmitt-Hoffmann, B, Roos, J, Sauer, T, Brown, E, Weidekamm, I, Meyer, M, Schleimer, J, Maares
Publikováno v:
Clinical and experimental dermatology. 36
Alitretinoin, like all retinoids, is teratogenic, and can only be given to women of childbearing potential if pregnancy is excluded and a strict contraceptive programme is followed.This study was designed to determine whether alitretinoin in the seme
Autor:
A H, Schmitt-Hoffmann, B, Roos, J, Sauer, M, Schleimer, A, Schoetzau, P T, Leese, E, Weidekamm, J, Maares
Publikováno v:
Clinical and experimental dermatology. 36
Alitretinoin (9-cis retinoic acid) is currently registered in many European countries and in Canada as the only licensed treatment for severe chronic hand eczema unresponsive to potent topical corticosteroids. Alitretinoin, like all retinoids, is ter
Autor:
E. Weidekamm
Publikováno v:
Journal of Chemotherapy. 5:475-479
Brodimoprim is a dihydrofolate reductase inhibitor which is highly active against a broad spectrum of gram-negative and gram-positive bacteria. Single dose pharmacokinetics and dose proportionality of this drug were studied in healthy volunteers who
Publikováno v:
Antimicrobial Agents and Chemotherapy, Vol. 37, No 10 (1993) pp. 2132-2138
Staphylococcus aureus infections have been successfully treated in animal models with the combination of fleroxacin and rifampin. We studied the influence of rifampin, a potent cytochrome P-450 inducer, on the pharmacokinetics and biotransformation o
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:293-296
Fleroxacin was administered to seven lactating women as a single oral dose of 400 mg. Plasma, urine, and milk samples were collected for up to 48 h after administration. Drug concentrations were determined by a reversed-phase high-pressure liquid chr
Autor:
G Muirhead, R Portmann, I Viachki, N Bacracheva, E Weidekamm, V Vlahov, K Stoeckel, W L Hayton
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:2375-2380
Patients with biliary tract infections received 800 mg of fleroxacin orally once daily on five consecutive days; cholecystectomy was on day 3. Starting on the day when dose 5 was administered, serial blood and T-drain bile samples were taken for 72 h